Piermont Capital Management Inc. - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 128 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q2 2017$532,000
-16.7%
85,500
-15.2%
0.15%0.0%
Q1 2017$639,000
+10.9%
100,770
+109.9%
0.15%
-12.6%
Q2 2015$576,00048,0200.17%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q2 2017
NameSharesValueWeighting ↓
Third Security, LLC 9,709,607$51,946,0002.80%
MILLER VALUE PARTNERS, LLC 4,900,721$26,219,0001.15%
MSD Partners, L.P. 3,410,500$18,246,0000.92%
Michael & Susan Dell Foundation 66,749$357,0000.26%
Glacier Peak Capital LLC 68,043$364,0000.21%
Vident Investment Advisory, LLC 114,980$615,0000.08%
SFMG, LLC 62,433$334,0000.07%
Virtus ETF Advisers LLC 40,359$216,0000.06%
Steward Partners Investment Advisory, LLC 23,187$124,0000.06%
O'Dell Group, LLC 10,142$54,0000.05%
View complete list of ZIOPHARM ONCOLOGY INC shareholders